VOJEA

Composition: Iron pyrophosphate microcapsules (corn starch, iron pyrophosphate, sunflower lecithin), microcrystalline cellulose (carrier), mono- and diglycerides of fatty acids (stabilizer), polyvinylpolypyrrolidone (stabilizer), cross-linked sodium carboxymethylcellulose (stabilizer), anti-caking agents: amorphous silicon dioxide and magnesium salts of fatty acids, Quatrefolic®* ((6S)-5-methyltetrahydrofolic acid, glucosamine salt).

Iron pyrophosphate microcapsules: 30 mg

Folic acid (as an active metabolite Quatrefolic®): 400 µg

Intended use: an additional source of iron and folic acids.

Short description: Vojea contains iron pyrophosphate microcapsules and the active metabolite of folic acid Quatrefolic®. Iron pyrophosphate microcapsule technology improves iron absorption and minimizes side effects – metallic taste in the mouth, functional gastrointestinal disorders.

Quatrefolic® has better absorption than ordinary folic acid by 9.7 times.

Recommended to use:

Additional source of iron and folic acid.
– planning pregnancy
– during pregnancy and breastfeeding
– for the prevention of anemia in women of reproductive age at risk for developing anemia 1 (heavy menstruation, chronic inflammatory diseases, etc.)
It is recommended to consult a doctor before taking.

Contraindications:

Individual intolerance to the components.

It is recommended to consult a doctor before use.

Pregnant and lactating women should take the dietary supplement on the recommendation and under the supervision of a doctor.

Drug Regimen:

Women, including those planning pregnancy, during pregnancy and breastfeeding, take 1 tablet once a day during meals with a sufficient amount of water (200-250 ml). Duration of administration is 1 month. If necessary, the administration can be repeated.

Bibliography:

I.N. Kononova, Ye.N. Kareva, Yu.E. Dobrokhotova. Quatrefolic®, active metabolite of the 4th generation of folic acid, & Lipofer®, micronized microencapsulated iron: innovative approaches in replenishing folic acid and iron deficiency in women. Literature Review. RMJ. Mother and Child. 2022;5(1):18-27. DOI: 10.32364/2618-8430-2022-5-1-18-27.